Brain Disorders Due to Lysosomal Dysfunction

Annual Review of Neuroscience

Volumn 39, Issue , 2016, Pages 277-295

  Fraldi, Alessandro ^a   Klein, Andrés D ^a   Medina, Diego L ^a   Settembre, Carmine ^a,b,c  

^a TELETHON INSTITUTE OF GENETICS AND MEDICINE TIGEM   (Italy)

^b DULBECCO TELETHON INSTITUTE   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Autophagy; Lysosomal storage disorders; Lysosome; Neurodegenerative diseases; TFEB; Transcription factor EB; synuclein

Indexed keywords

ALPHA SYNUCLEIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; TRANSCRIPTION FACTOR;

ALZHEIMER DISEASE; ARTICLE; AUTOPHAGY; BIOGENESIS; BRAIN DISEASE; CELL ORGANELLE; EXPERIMENTAL THERAPY; GENE EXPRESSION REGULATION; HUMAN; HUNTINGTON CHOREA; LYSOSOME; LYSOSOME STORAGE DISEASE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; BRAIN; GENE EXPRESSION; HOMEOSTASIS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; AUTOPHAGY; BRAIN; BRAIN DISEASES; GENE EXPRESSION; HOMEOSTASIS; HUMANS; LYSOSOMES;

EID: 84979620089     PISSN: 0147006X     EISSN: 15454126     Source Type: Book Series    
DOI: 10.1146/annurev-neuro-070815-014031     Document Type: Article

References (138)

1. Arias E, Koga H, Diaz A, Mocholi E, Patel B, Cuervo AM. 2015. LysosomalmTORC2/PHLPP1/Akt regulate chaperone-mediated autophagy. Mol. Cell 59: 270-84
2. Bar-On P, Rockenstein E, AdameA, HoG, Hashimoto M, Masliah E. 2006. Effects of the cholesterol-lowering compound methyl-cyclodextrin in models of-synucleinopathy. J. Neurochem. 98: 1032-45
3. BasuRay S, Mukherjee S, Romero EG, Seaman MN, Wandinger-Ness A. 2013. Rab7 mutants associated with Charcot-Marie-Tooth disease cause delayed growth factor receptor transport and altered endosomal and nuclear signaling. J. Biol. Chem. 288: 1135-49
4. Bellettato CM, Scarpa M. 2010. Pathophysiology of neuropathic lysosomal storage disorders. J. Inherit. Metab. Dis. 33: 347-62
5. Bertram L, Tanzi RE. 2005. The genetic epidemiology of neurodegenerative disease. J. Clin. Investig. 115: 1449-57
6. Boustany RM. 2013. Lysosomal storage diseases-the horizon expands. Nat. Rev. Neurol. 9: 583-98
7. Bras J, Guerreiro R, Hardy J. 2015. SnapShot: genetics of Parkinson's disease. Cell 160: 570-70
8. Bras J, Verloes A, Schneider SA, Mole SE, Guerreiro RJ. 2012. Mutation of the Parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis. Hum. Mol. Genet. 21: 2646-50
9. Burgoyne RD, Morgan A. 2011. Chaperoning the SNAREs: A role in preventing neurodegeneration? Nat. Cell Biol. 13: 8-9
10. Burre J, Sharma M, Tsetsenis T, Buchman V, Etherton MR, Sudhof TC. 2010.-Synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 329: 1663-67
11. Butler JD, Vanier MT, Pentchev PG. 1993. Niemann-Pick C disease: Cystine and lipids accumulate in the murine model of this lysosomal cholesterol lipidosis. Biochem. Biophys. Res. Commun. 196: 154-59
12. Cang C, Aranda K, Seo YJ, Gasnier B, Ren D. 2015. TMEM175 is an organelle K+ channel regulating lysosomal function. Cell 162: 1101-12
13. CangC, ZhouY, Navarro B, Seo YJ, Aranda K, et al. 2013. mTORregulates lysosomalATP-sensitive two-pore Na+ channels to adapt to metabolic state. Cell 152: 778-90
14. Cao Q, Zhong XZ, Zou Y, Murrell-Lagnado R, Zhu MX, Dong XP. 2015. Calcium release through P2X4 activates calmodulin to promote endolysosomal membrane fusion. J. Cell Biol. 209: 879-94
15. Chen FW, Li C, Ioannou YA. 2010. Cyclodextrin induces calcium-dependent lysosomal exocytosis. PLOS ONE 5: e15054
16. Coen K, Flannagan RS, Baron S, Carraro-Lacroix LR, Wang D, et al. 2012. Lysosomal calcium homeostasis defects, not proton pump defects, cause endo-lysosomal dysfunction in PSEN-deficient cells. J. Cell Biol. 198: 23-35
17. Cortes CJ, Miranda HC, Frankowski H, Batlevi Y, Young JE, et al. 2014. Polyglutamine-expanded androgen receptor interferes with TFEB to elicit autophagy defects in SBMA. Nat. Neurosci. 17: 1180-89
18. Cuervo AM, Dice JF. 2000. When lysosomes get old. Exp. Gerontol. 35: 119-31
19. Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D. 2004. Impaired degradation of mutant-synuclein by chaperone-mediated autophagy. Science 305: 1292-95
20. Curcio-Morelli C, Charles FA, Micsenyi MC, Cao Y, Venugopal B, et al. 2010. Macroautophagy is defective in mucolipin-1-deficient mouse neurons. Neurobiol. Dis. 40: 370-77
21. Das U, Scott DA, Ganguly A, Koo EH, Tang Y, Roy S. 2013. Activity-induced convergence of APP and BACE-1 in acidic microdomains via an endocytosis-dependent pathway. Neuron 79: 447-60
22. Davies JP, Chen FW, Ioannou YA. 2000. Transmembrane molecular pump activity of Niemann-Pick C1 protein. Science 290: 2295-98
23. De Duve C, Pressman BC, Gianetto R, Wattiaux R, Appelmans F. 1955. Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue. Biochem. J. 60: 604-17
24. de Pablo-Latorre R, Saide A, Polishhuck EV, Nusco E, Fraldi A, Ballabio A. 2012. Impaired parkin-mediated mitochondrial targeting to autophagosomes differentially contributes to tissue pathology in lysosomal storage diseases. Hum. Mol. Genet. 21: 1770-81
25. DecressacM, Bjorklund A. 2013. TFEB: Pathogenic role and therapeutic target in Parkinson disease. Autophagy 9: 1244-46
26. DecressacM, MattssonB, WeikopP, LundbladM, Jakobsson J, Bjorklund A. 2013. TFEB-mediated autophagy rescues midbrain dopamine neurons from-synuclein toxicity. PNAS 110: E1817-26
27. Di Malta C, Fryer JD, Settembre C, Ballabio A. 2012. Astrocyte dysfunction triggers neurodegeneration in a lysosomal storage disorder. PNAS 109: E2334-42
28. Dong XP, Wang X, Shen D, Chen S, Liu M, et al. 2009. Activating mutations of the TRPML1 channel revealed by proline-scanning mutagenesis. J. Biol. Chem. 284: 32040-52
29. Enquist IB, Lo Bianco C, Ooka A, Nilsson E, Mansson JE, et al. 2007. Murine models of acute neuronopathic Gaucher disease. PNAS 104: 17483-88
30. Eskelinen EL. 2006. Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy. Mol. Asp. Med. 27: 495-502
31. Fernandes Filho JA, Shapiro BE. 2004. Tay-Sachs disease. Arch. Neurol. 61: 1466-68
32. Fraldi A, Annunziata F, Lombardi A, Kaiser HJ, Medina DL, et al. 2010. Lysosomal fusion and SNARE function are impaired by cholesterol accumulation in lysosomal storage disorders. EMBO J. 29: 3607-20
33. Fraldi A, Hemsley K, Crawley A, Lombardi A, Lau A, et al. 2007. Functional correction of CNS lesions in an MPS-IIIA mouse model by intracerebral AAV-mediated delivery of sulfamidase and SUMF1 genes. Hum. Mol. Genet. 16: 2693-702
34. Freeman D, Cedillos R, Choyke S, Lukic Z, McGuire K, et al. 2013.-Synuclein induces lysosomal rupture and cathepsin dependent reactive oxygen species following endocytosis. PLOS ONE 8: e62143
35. Futerman AH, van Meer G. 2004. The cell biology of lysosomal storage disorders. Nat. Rev. Mol. Cell Biol. 5: 554-65
36. Geisler S, HolmstromKM, Treis A, SkujatD, Weber SS, et al. 2010. The PINK1/Parkin-mediated mitophagy is compromised by PD-associated mutations. Autophagy 6: 871-78
37. Graves AR, Curran PK, Smith CL, Mindell JA. 2008. The CL/H+ antiporter ClC-7 is the primary chloride permeation pathway in lysosomes. Nature 453: 788-92
38. Hamasaki M, Furuta N, Matsuda A, Nezu A, Yamamoto A, et al. 2013. Autophagosomes form at ER-mitochondria contact sites. Nature 495: 389-93
39. Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, et al. 2006. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441: 885-89
40. Harris H, Rubinsztein DC. 2012. Control of autophagy as a therapy for neurodegenerative disease. Nat. Rev. Neurol. 8: 108-17
41. Jardim LB, Villanueva MM, de Souza CF, Netto CB. 2010. Clinical aspects of neuropathic lysosomal storage disorders. J. Inherit. Metab. Dis. 33: 315-29
42. Jeong H, Then F, Melia TJ Jr., Mazzulli JR, Cui L, et al. 2009. Acetylation targets mutant huntingtin to autophagosomes for degradation. Cell 137: 60-72
43. Kalatzis V, Cherqui S, Antignac C, Gasnier B. 2001. Cystinosin, the protein defective in cystinosis, is a H+-driven lysosomal cystine transporter. EMBO J. 20: 5940-49
44. Kilpatrick K, Zeng Y, Hancock T, Segatori L. 2015. Genetic and chemical activation of TFEB mediates clearance of aggregated-synuclein. PLOS ONE 10: e0120819
45. Kim HJ, Soyombo AA, Tjon-Kon-Sang S, So I, Muallem S. 2009. The Ca2+ channel TRPML3 regulates membrane trafficking and autophagy. Traffic 10: 1157-67
46. Klein AD, Futerman AH. 2013. Lysosomal storage disorders: old diseases, present and future challenges. Pediatr. Endocrinol. Rev. 11(Suppl. 1): 59-63
47. Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, et al. 2006. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441: 880-84
48. Komatsu M, Wang QJ, Holstein GR, Friedrich VL Jr., Iwata J, et al. 2007. Essential role for autophagy protein Atg7 in the maintenance of axonal homeostasis and the prevention of axonal degeneration. PNAS 104: 14489-94
49. Kramer ML, Schulz-Schaeffer WJ. 2007. Presynaptic-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J. Neurosci. 27: 1405-10
50. Kummel D, Ungermann C. 2014. Principles of membrane tethering and fusion in endosome and lysosome biogenesis. Curr. Opin. Cell Biol. 29: 61-66
51. LaPlante JM, Sun M, Falardeau J, Dai D, Brown EM, et al. 2006. Lysosomal exocytosis is impaired in mucolipidosis type IV. Mol. Genet. Metab. 89: 339-48
52. Lee HJ, Khoshaghideh F, Patel S, Lee SJ. 2004. Clearance of-synuclein oligomeric intermediates via the lysosomal degradation pathway. J. Neurosci. 24: 1888-96
53. Lee JH, McBrayer MK, Wolfe DM, Haslett LJ, Kumar A, et al. 2015. Presenilin 1 maintains lysosomal Ca2+ homeostasis via TRPML1 by regulating vATPase-mediated lysosome acidification. Cell Rep. 12: 1430-44
54. Lee JH, Yu WH, Kumar A, Lee S, Mohan PS, et al. 2010. Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell 141: 1146-58
55. Lee S, Sato Y, Nixon RA. 2011. Lysosomal proteolysis inhibition selectively disrupts axonal transport of degradative organelles and causes an Alzheimer's-like axonal dystrophy. J. Neurosci. 31: 7817-30
56. Lee SM, Chin LS, Li L. 2012. Charcot-Marie-Tooth disease-linked protein SIMPLE functions with the ESCRT machinery in endosomal trafficking. J. Cell Biol. 199: 799-816
57. Li JQ, Tan L, Yu JT. 2014. The role of the LRRK2 gene in Parkinsonism. Mol. Neurodegener. 9: 47
58. Lieberman AP, Puertollano R, Raben N, Slaugenhaupt S, Walkley SU, Ballabio A. 2012. Autophagy in lysosomal storage disorders. Autophagy 8: 719-30
59. Liu B, Du H, Rutkowski R, Gartner A, Wang X. 2012. LAAT-1 is the lysosomal lysine/arginine transporter that maintains amino acid homeostasis. Science 337: 351-54
60. Liu L, Zhang K, Sandoval H, Yamamoto S, Jaiswal M, et al. 2015. Glial lipid droplets and ROS induced by mitochondrial defects promote neurodegeneration. Cell 160: 177-90
61. Lloyd-Evans E, Morgan AJ, He X, Smith DA, Elliot-Smith E, et al. 2008. Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium. Nat. Med. 14: 1247-55
62. Lopez ME, Klein AD, Dimbil UJ, Scott MP. 2011. Anatomically defined neuron-based rescue of neurodegenerative Niemann-Pick type C disorder. J. Neurosci. 31: 4367-78
63. Lundblad M, Decressac M, Mattsson B, Bjorklund A. 2012. Impaired neurotransmission caused by overexpression of-synuclein in nigral dopamine neurons. PNAS 109: 3213-19
64. Luzi P, Abraham RM, Rafi MA, Curtis M, Hooper DC, Wenger DA. 2009. Effects of treatments on inflammatory and apoptotic markers in the CNS of mice with globoid cell leukodystrophy. Brain Res. 1300: 146-58
65. Macauley SL, Wong AM, Shyng C, Augner DP, Dearborn JT, et al. 2014. An anti-neuroinflammatory that targets dysregulated glia enhances the efficacy of CNS-directed gene therapy inmurine infantile neuronal ceroid lipofuscinosis. J. Neurosci. 34: 13077-82
66. Mak SK, McCormack AL, Manning-Bog AB, Cuervo AM, Di Monte DA. 2010. Lysosomal degradation of-synuclein in vivo. J. Biol. Chem. 285: 13621-29
67. March PA, Thrall MA, Brown DE, Mitchell TW, Lowenthal AC, Walkley SU. 1997. GABAergic neuroaxonal dystrophy and other cytopathological alterations in felineNiemann-Pick disease typeC. Acta Neuropathol. 94: 164-72
68. Martina JA, Chen Y, Gucek M, Puertollano R. 2012. MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB. Autophagy 8: 903-14
69. Martinez-Vicente M, Talloczy Z, Kaushik S, Massey AC, Mazzulli J, et al. 2008. Dopamine-modified-synuclein blocks chaperone-mediated autophagy. J. Clin. Investig. 118: 777-88
70. Mazzulli JR, Xu YH, Sun Y, Knight AL, McLean PJ, et al. 2011. Gaucher disease glucocerebrosidase and-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 146: 37-52
71. Medina DL, Di Paola S, Peluso I, Armani A, De Stefani D, et al. 2015. Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB. Nat. Cell Biol. 17: 288-99
72. Medina DL, Fraldi A, Bouche V, Annunziata F, Mansueto G, et al. 2011. Transcriptional activation of lysosomal exocytosis promotes cellular clearance. Dev. Cell 21: 421-30
73. Menzies FM, Fleming A, Rubinsztein DC. 2015. Compromised autophagy and neurodegenerative diseases. Nat. Rev. Neurosci. 16: 345-57
74. Micsenyi MC, Dobrenis K, Stephney G, Pickel J, Vanier MT, et al. 2009. Neuropathology of the Mcoln1 knockout mouse model of mucolipidosis type IV. J. Neuropathol. Exp. Neurol. 68: 125-35
75. Mindell JA. 2012. Lysosomal acidification mechanisms. Annu. Rev. Physiol. 74: 69-86
76. Mizushima N. 2007. Autophagy: Process and function. Genes Dev. 21: 2861-73
77. Moskot M, Montefusco S, Jakobkiewicz-Banecka J, Mozolewski P, Wegrzyn A, et al. 2014. The phytoestrogen genistein modulates lysosomal metabolism and transcription factor EB (TFEB) activation. J. Biol. Chem. 289: 17054-69
78. Nemani VM, LuW, Berge V, Nakamura K, Onoa B, et al. 2010. Increased expression of-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron 65: 66-79
79. Nishino I, Fu J, Tanji K, Yamada T, Shimojo S, et al. 2000. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature 406: 906-10
80. Nixon RA, Yang DS, Lee JH. 2008. Neurodegenerative lysosomal disorders: A continuum from development to late age. Autophagy 4: 590-99
81. Ostrerova N, Petrucelli L, FarrerM, Mehta N, Choi P, et al. 1999.-Synuclein shares physical and functional homology with 14-3-3 proteins. J. Neurosci. 19: 5782-91
82. Palmieri M, Impey S, Kang H, di Ronza A, Pelz C, et al. 2011. Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways. Hum. Mol. Genet. 20: 3852-66
83. Pastores GM, Maegawa GH. 2013. Clinical neurogenetics: neuropathic lysosomal storage disorders. Neurol. Clin. 31: 1051-71
84. Perez RG, Waymire JC, Lin E, Liu JJ, Guo F, Zigmond MJ. 2002. A role for-synuclein in the regulation of dopamine biosynthesis. J. Neurosci. 22: 3090-99
85. Platt FM, Boland B, van der Spoel AC. 2012. Lysosomal storage disorders: the cellular impact of lysosomal dysfunction. J. Cell Biol. 199: 723-34
86. Polito VA, Li H, Martini-Stoica H, Wang B, Yang L, et al. 2014. Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB. EMBO Mol. Med. 6: 1142-60
87. Rajendran L, AnnaertW. 2012. Membrane trafficking pathways in Alzheimer's disease. Traffic 13: 759-70
88. Rama Rao KV, Kielian T. 2016. Astrocytes and lysosomal storage diseases. Neuroscience 323: 195-206
89. Ramirez A, Heimbach A, Grundemann J, Stiller B, Hampshire D, et al. 2006. Hereditary Parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat. Genet. 38: 1184-91
90. Ravikumar B, Acevedo-Arozena A, Imarisio S, Berger Z, Vacher C, et al. 2005. Dynein mutations impair autophagic clearance of aggregate-prone proteins. Nat. Genet. 37: 771-76
91. Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, et al. 2004. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet. 36: 585-95
92. Roczniak-Ferguson A, Petit CS, Froehlich F, Qian S, Ky J, et al. 2012. The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis. Sci. Signal. 5: ra42
93. Rogov V, Dotsch V, JohansenT, Kirkin V. 2014. Interactions between autophagy receptors and ubiquitin-like proteins form the molecular basis for selective autophagy. Mol. Cell 53: 167-78
94. Rong Y, McPhee CK, Deng S, Huang L, Chen L, et al. 2011. Spinster is required for autophagic lysosome reformation and mTOR reactivation following starvation. PNAS 108: 7826-31
95. Rui YN, Xu Z, Patel B, Chen Z, Chen D, et al. 2015. Huntingtin functions as a scaffold for selective macroautophagy. Nat. Cell Biol. 17: 262-75
96. Saez PJ, Orellana JA, Vega-Riveros N, Figueroa VA, Hernandez DE, et al. 2013. Disruption in connexin-based communication is associated with intracellular Ca2+ signal alterations in astrocytes from Niemann-Pick type C mice. PLOS ONE 8: e71361
97. Saftig P, Klumperman J. 2009. Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function. Nat. Rev. Mol. Cell Biol. 10: 623-35
98. Sagne C, Agulhon C, Ravassard P, Darmon M, Hamon M, et al. 2001. Identification and characterization of a lysosomal transporter for small neutral amino acids. PNAS 98: 7206-11
99. Samie M, Wang X, Zhang X, Goschka A, Li X, et al. 2013. A TRP channel in the lysosome regulates large particle phagocytosis via focal exocytosis. Dev. Cell 26: 511-24
100. Sancak Y, Bar-Peled L, Zoncu R, Markhard AL, Nada S, Sabatini DM. 2010. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 141: 290-303
101. Sancak Y, Peterson TR, Shaul YD, Lindquist RA, Thoreen CC, et al. 2008. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320: 1496-501
102. Sardiello M, Palmieri M, di Ronza A, Medina DL, ValenzaM, et al. 2009. A gene network regulating lysosomal biogenesis and function. Science 325: 473-77
103. Scheff SW, Price DA, Schmitt FA, DeKosky ST, Mufson EJ. 2007. Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 68: 1501-8
104. Schulze H, Sandhoff K. 2011. Lysosomal lipid storage diseases. Cold Spring Harb. Perspect. Biol. 3: A004804
105. Settembre C, Di Malta C, Polito VA, Garcia Arencibia M, Vetrini F, et al. 2011. TFEB links autophagy to lysosomal biogenesis. Science 332: 1429-33
106. Settembre C, Fraldi A, Jahreiss L, Spampanato C, Venturi C, et al. 2008. A block of autophagy in lysosomal storage disorders. Hum. Mol. Genet. 17: 119-29
107. Settembre C, Fraldi A, Medina DL, Ballabio A. 2013. Signals from the lysosome: A control centre for cellular clearance and energy metabolism. Nat. Rev. Mol. Cell Biol. 14: 283-96
108. Settembre C, Zoncu R, Medina DL, Vetrini F, Erdin S, et al. 2012. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J. 31: 1095-108
109. Shachar T, Lo Bianco C, Recchia A, Wiessner C, Raas-Rothschild A, Futerman AH. 2011. Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond. Mov. Disord. 26: 1593-604
110. Shen D, Wang X, Li X, Zhang X, Yao Z, et al. 2012. Lipid storage disorders block lysosomal trafficking by inhibiting a TRP channel and lysosomal calcium release. Nat. Commun. 3: 731
111. Sidransky E, Nalls MA, Aasly JO, Aharon-Peretz J, Annesi G, et al. 2009. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N. Engl. J. Med. 361: 1651-61
112. Siegel DA, Walkley SU. 1994. Growth of ectopic dendrites on cortical pyramidal neurons in neuronal storage diseases correlates with abnormal accumulation of GM2 ganglioside. J. Neurochem. 62: 1852-62
113. Singh R, Kaushik S, Wang Y, Xiang Y, Novak I, et al. 2009. Autophagy regulates lipid metabolism. Nature 458: 1131-35
114. Song CY, Guo JF, Liu Y, Tang BS. 2012. Autophagy and its comprehensive impact on ALS. Int. J. Neurosci. 122: 695-703
115. Song W, Wang F, Lotfi P, Sardiello M, Segatori L. 2014. 2-Hydroxypropyl-cyclodextrin promotes transcription factor EB-mediated activation of autophagy: implications for therapy. J. Biol. Chem. 289: 10211-22
116. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. 1997.-Synuclein in Lewy bodies. Nature 388: 839-40
117. te Vruchte D, Lloyd-Evans E, Veldman RJ, Neville DC, Dwek RA, et al. 2004. Accumulation of glycosphingolipids in Niemann-Pick C disease disrupts endosomal transport. J. Biol. Chem. 279: 26167-75
118. Tian X, Gala U, Zhang Y, Shang W, Nagarkar Jaiswal S, et al. 2015. A voltage-gated calcium channel regulates lysosomal fusion with endosomes and autophagosomes and is required for neuronal homeostasis. PLOS Biol. 13: e1002103
119. Tsunemi T, Ashe TD, Morrison BE, Soriano KR, Au J, et al. 2012. PGC-1 rescues Huntington's disease proteotoxicity by preventing oxidative stress and promoting TFEB function. Sci. Transl. Med. 4: 142ra97
120. Vergarajauregui S, Connelly PS, Daniels MP, Puertollano R. 2008. Autophagic dysfunction in mucolipidosis type IV patients. Hum. Mol. Genet. 17: 2723-37
121. Verheijen FW, Verbeek E, Aula N, Beerens CE, Havelaar AC, et al. 1999. A new gene, encoding an anion transporter, is mutated in sialic acid storage diseases. Nat. Genet. 23: 462-65
122. Vitner EB, Futerman AH, Platt N. 2015. Innate immune responses in the brain of sphingolipid lysosomal storage diseases. Biol. Chem. 396: 659-67
123. VitnerEB, SalomonR, Farfel-Becker T, MeshcheriakovaA, Ali M, et al. 2014. RIPK3 as a potential therapeutic target for Gaucher's disease. Nat. Med. 20: 204-8
124. Walker FO. 2007. Huntington's disease. Lancet 369: 218-28
125. Wang W, Gao Q, Yang M, Zhang X, Yu L, et al. 2015. Up-regulation of lysosomal TRPML1 channels is essential for lysosomal adaptation to nutrient starvation. PNAS 112: E1373-81
126. Williams IM, Wallom KL, Smith DA, Al Eisa N, Smith C, Platt FM. 2014. Improved neuroprotection using miglustat, curcumin and ibuprofen as a triple combination therapy in Niemann-Pick disease type C1 mice. Neurobiol. Dis. 67: 9-17
127. Winslow AR, Chen CW, Corrochano S, Acevedo-Arozena A, Gordon DE, et al. 2010.-Synuclein impairs macroautophagy: implications for Parkinson's disease. J. Cell Biol. 190: 1023-37
128. Wong E, Cuervo AM. 2010. Autophagy gone awry in neurodegenerative diseases. Nat. Neurosci. 13: 805-11
129. Wong YC, Holzbaur EL. 2014. The regulation of autophagosome dynamics by huntingtin and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo degradation. J. Neurosci. 34: 1293-305
130. Wu YP, Proia RL. 2004. Deletion of macrophage-inflammatory protein 1 retards neurodegeneration in Sandhoff disease mice. PNAS 101: 8425-30
131. Xu M, Liu K, Swaroop M, Porter FD, Sidhu R, et al. 2012.-Tocopherol reduces lipid accumulation in Niemann-Pick type C1 andWolman cholesterol storage disorders. J. Biol. Chem. 287: 39349-60
132. Yamamoto A, Cremona ML, Rothman JE. 2006. Autophagy-mediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway. J. Cell Biol. 172: 719-31
133. Yao J, Ho D, Calingasan NY, Pipalia NH, Lin MT, Beal MF. 2012. Neuroprotection by cyclodextrin in cell and mouse models of Alzheimer disease. J. Exp. Med. 209: 2501-13
134. Yu L, McPhee CK, Zheng L, Mardones GA, Rong Y, et al. 2010. Termination of autophagy and reformation of lysosomes regulated by mTOR. Nature 465: 942-46
135. Yu T, Shakkottai VG, Chung C, Lieberman AP. 2011. Temporal and cell-specific deletion establishes that neuronal Npc1 deficiency is sufficient to mediate neurodegeneration. Hum. Mol. Genet. 20: 4440-51
136. Zimprich A, Benet-Pages A, Struhal W, Graf E, Eck SH, et al. 2011. Amutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am. J. Hum. Genet. 89: 168-75
137. Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, et al. 2004. Mutations in LRRK2 cause autosomaldominant Parkinsonism with pleomorphic pathology. Neuron 44: 601-7
138. Zoncu R, Bar-Peled L, Efeyan A, Wang S, Sancak Y, Sabatini DM. 2011. mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H+-ATPase. Science 334: 678-83